MJayawardena
TL3 Regular · Kuopio, FI
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 11 August 2024 · last posted 18h
144 posts, newest first. Showing up to 150.
-
Coming back to: A structured critique template this community uses Replied, post #70 · Evidence › Study critique · 27 Jul 2026 · 13 likes I read post #68 twice before replying, because I had assumed the opposite. Criticise the method, not the author: a paper with a weak design is not a bad paper by…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #72 · Access › Insurance & coverage · 26 Jul 2026 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
About the Independent verification category Replied, post #5 · Sourcing › Independent verification · 24 Jul 2026 · 6 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #116 · Analytics › Home & field testing · 23 Jul 2026 · 7 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #86 · Compounds › Retatrutide · 23 Jul 2026 · 0 likes Coming back to post #84, because the follow-up matters more than the original answer. Triple agonism: is the effect additive, synergistic, or neither? A phase 2…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #62 · Clinical › Prescriber conversations · 21 Jul 2026 · 9 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Athletes in weight-category sports: a different risk calculus Replied, post #33 · Clinical › Special populations · 20 Jul 2026 · 7 likes Picking up post #30: that is the part I would want checked first. Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease.…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #15 · Clinical › Prescriber conversations · 19 Jul 2026 · 10 likes This follows post #12 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #13 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #3 · Compounds › Oral incretins · 16 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #126 · Practice › Reconstitution · 15 Jul 2026 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
What steady state means for the decision to escalate Replied, post #25 · Practice › Dosing & titration · 7 Jul 2026 · 0 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #44 · Analytics › Impurities & related substances · 3 Jul 2026 · 12 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
CJC-1295 with and without DAC: what the modification does Replied, post #99 · Compounds › Secretagogues & GH axis · 1 Jul 2026 · 1 like Worth separating two things that post #95 runs together. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely…
-
Journal club: what we got wrong in an earlier session Replied, post #38 · Evidence › Journal club · 29 Jun 2026 · 9 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Talking to a therapist about this specifically Replied, post #14 · Wellbeing › Mental health · 20 Jun 2026 · 23 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #43 · Clinical › Bloodwork · 12 Jun 2026 · 5 likes post #42 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: Reading an interaction checker output critically Started this topic · Practice › Interactions · 8 Jun 2026 · 0 likes Reading an interaction checker output critically — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I…
-
A pooled estimate that changed when one trial was added Replied, post #7 · Evidence › Meta-analyses · 7 Jun 2026 · 19 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Tracking a shortage from primary sources rather than rumour Replied, post #35 · Access › Shortages · 4 Jun 2026 · 5 likes post #34 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A site rotation scheme that is easy enough to actually follow Replied, post #73 · Practice › Administration · 27 May 2026 · 11 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #93 · Compounds › Tirzepatide · 26 May 2026 · 4 likes This follows post #90 rather than contradicting it. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #84 · Compounds › Tirzepatide · 24 May 2026 · 32 likes post #83 answers the question as asked. The question underneath it is different. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #119 · Practice › Storage & stability · 20 May 2026 · 4 likes Worth separating two things that post #115 runs together. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #3 · Sourcing › Red flags · 19 May 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #16 · Analytics › Method validation · 11 May 2026 · 20 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
The headache that turns out to be dehydration — the long version Replied, post #33 · Nutrition & Training › Hydration & electrolytes · 10 May 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #100 · Research Methods › Statistics · 9 May 2026 · 2 likes post #99 answers the question as asked. The question underneath it is different. Confidence intervals: rather than a single point estimate, a range of plausible values.…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #19 · Sourcing › Logistics · 6 May 2026 · 20 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #25 · Analytics › COA interpretation · 2 May 2026 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
The headache that turns out to be dehydration — the long version Replied, post #24 · Nutrition & Training › Hydration & electrolytes · 20 Apr 2026 · 12 likes Coming back to post #22, because the follow-up matters more than the original answer. Lab testing: if symptoms are severe or persistent, checking electrolytes and…
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #16 · Pharmacology › Pharmacokinetics · 14 Apr 2026 · 6 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Spike-and-recover accuracy for a peptide assay Replied, post #68 · Analytics › Method validation · 9 Apr 2026 · 14 likes On post #64 — agreed on the reasoning, with one qualification. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #26 · Evidence › Journal club · 8 Apr 2026 · 4 likes post #25 answers the question as asked. The question underneath it is different. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Sample handling between despatch and injection Replied, post #12 · Analytics › Method validation · 1 Apr 2026 · 22 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #86 · Pharmacology › Pharmacokinetics · 28 Mar 2026 · 29 likes Worth separating two things that post #82 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #64 · Sourcing › Logistics · 28 Mar 2026 · 18 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #38 · Sourcing › Vendor reports · 20 Mar 2026 · 16 likes This follows post #35 rather than contradicting it. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a…
-
Five questions in one post gets you one answer — how to split them Replied, post #31 · Start Here › How to Ask · 14 Mar 2026 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25…
-
Whether protein timing matters at a large deficit Replied, post #33 · Nutrition & Training › Protein & intake · 12 Mar 2026 · 6 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #2 · Practice › Side effects · 11 Mar 2026 · 24 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #139 · Compounds › Semaglutide · 9 Mar 2026 · 17 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #22 · Evidence › Trials · 7 Mar 2026 · 27 likes Worth separating two things that post #18 runs together. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index…
-
The lowest dose that does anything: is that a real question? Replied, post #55 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #46 · Practice › Reconstitution · 26 Feb 2026 · 9 likes post #45 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #69 · Evidence › Study critique · 20 Feb 2026 · 0 likes Worth separating two things that post #65 runs together. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you…
-
Angle of injection and whether 90 degrees is always right Replied, post #101 · Practice › Administration · 16 Feb 2026 · 3 likes Coming back to post #99, because the follow-up matters more than the original answer. Bleeding at the injection site: normal and usually minimal. A little blood at the…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #119 · Sourcing › Independent verification · 12 Feb 2026 · 1 like Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Heterogeneity as information rather than as a nuisance Replied, post #91 · Evidence › Meta-analyses · 5 Feb 2026 · 21 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #60 · Meta › Site feedback · 2 Feb 2026 · 21 likes Worth separating two things that post #56 runs together. Search and findability: if you searched for something and did not find it, report what you searched for and…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #83 · Access › International · 31 Jan 2026 · 26 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Specification in the result column: why that is a meaningful error Replied, post #110 · Analytics › COA interpretation · 23 Jan 2026 · 4 likes post #109 is right about the mechanism and I think understates the practical bit. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #68 · Access › International · 22 Jan 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #21 · Clinical › Special populations · 21 Jan 2026 · 18 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #14 · Clinical › Special populations · 21 Jan 2026 · 10 likes Coming back to post #12, because the follow-up matters more than the original answer. Adolescents: a distinct evidence base exists. The compounds are not approved for…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #45 · Regional › UK & Ireland · 7 Jan 2026 · 0 likes Coming back to post #43, because the follow-up matters more than the original answer. Supply and shortage resilience: both UK and Ireland sourced primarily from…
-
Reverse causation in a cohort study of weight and outcome Replied, post #8 · Evidence › Study critique · 30 Dec 2025 · 1 like On post #4 — agreed on the reasoning, with one qualification. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not…
-
Research-use-only labelling: what it means and what it does not Replied, post #78 · Sourcing › Regulatory · 26 Dec 2025 · 13 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #76 · Compounds › Oral incretins · 21 Dec 2025 · 18 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #13 · Compounds › Oral incretins · 17 Dec 2025 · 0 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Tracking a preprint to publication: a worked example Replied, post #37 · Evidence › Preprints · 3 Dec 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #2 · Clinical › Comorbidities · 28 Nov 2025 · 26 likes Picking up the opening post: that is the part I would want checked first. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #19 · Evidence › Trials · 28 Nov 2025 · 9 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #38 · Compounds › Oral incretins · 10 Nov 2025 · 6 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
[2026 update] What steady state means for the decision to escalate Replied, post #21 · Practice › Dosing & titration · 6 Nov 2025 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] What steady state means for the decision to escalate Replied, post #18 · Practice › Dosing & titration · 6 Nov 2025 · 15 likes Worth separating two things that post #14 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #158 · Practice › Reconstitution · 3 Nov 2025 · 17 likes This follows post #155 rather than contradicting it. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #110 · Practice › Storage & stability · 29 Oct 2025 · 0 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #127 · Compounds › Tirzepatide · 24 Oct 2025 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #18 · Clinical › Special populations · 23 Oct 2025 · 11 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
Payment mechanics and the recovery options that do not exist Replied, post #4 · Sourcing › Payments · 18 Oct 2025 · 5 likes This follows post #2 rather than contradicting it. Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer.…
-
Follow-up: Why appetite effects are mostly central Replied, post #67 · Pharmacology › Receptor biology · 14 Oct 2025 · 22 likes Picking up post #64: that is the part I would want checked first. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor…
-
Compounds this community declines to help with, and why Replied, post #69 · Compounds › Other compounds · 6 Oct 2025 · 15 likes I read post #67 twice before replying, because I had assumed the opposite. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
Second pass at: The mass-error checker and its intended scope Replied, post #30 · Data & Tools › Calculators · 3 Oct 2025 · 7 likes I read post #28 twice before replying, because I had assumed the opposite. Storage lookup: which conditions (temperature, time) are you considering storing in, and how…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #69 · Practice › Administration · 19 Sep 2025 · 8 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Payment method and the leverage it gives you, ranked Replied, post #30 · Sourcing › Payments · 18 Sep 2025 · 22 likes I read post #28 twice before replying, because I had assumed the opposite. Documentation and tax implications: payments you make for compounds might have implications…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #40 · Lounge › Off topic · 16 Sep 2025 · 2 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #114 · Evidence › Study critique · 16 Sep 2025 · 4 likes post #113 answers the question as asked. The question underneath it is different. Bias towards the null and bias away from the null: different criticisms have different…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #151 · Data & Tools › Datasets · 11 Sep 2025 · 26 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #37 · Analytics › Method validation · 7 Sep 2025 · 1 like Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Managing an unplanned gap in supply — what changed since Replied, post #55 · Access › Shortages · 6 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
When a preprint is the best available evidence and we say so Replied, post #134 · Evidence › Preprints · 3 Sep 2025 · 9 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #114 · Practice › Reconstitution · 28 Aug 2025 · 30 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #104 · Compounds › Secretagogues & GH axis · 27 Aug 2025 · 0 likes On post #100 — agreed on the reasoning, with one qualification. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #8 · Evidence › Journal club · 9 Aug 2025 · 5 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
A ten-fold dose error caught before injection — one year on Replied, post #120 · Devices › Syringes & needles · 4 Aug 2025 · 26 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #52 · Clinical › Special populations · 2 Aug 2025 · 0 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
What a reversed-phase purity number actually is — the long version Started this topic · Analytics › HPLC & UHPLC · 26 Jul 2025 · 49 likes What a reversed-phase purity number actually is — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. I would…
-
Thyroid function tests during substantial weight change Replied, post #12 · Clinical › Bloodwork · 23 Jul 2025 · 7 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Substitution between formats during a shortage Replied, post #26 · Access › Shortages · 21 Jul 2025 · 4 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Counter-ion content and its effect on measured mass Replied, post #97 · Analytics › Mass spectrometry · 20 Jul 2025 · 1 like Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Interim analyses and stopping rules — does this still hold? Replied, post #28 · Evidence › Trials · 3 Jul 2025 · 31 likes On post #24 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Repeatability versus intermediate precision Replied, post #94 · Analytics › Method validation · 29 Jun 2025 · 0 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #9 · Compounds › Tirzepatide · 28 Jun 2025 · 8 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #39 · Meta › Wiki maintenance · 26 Jun 2025 · 0 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
Subcutaneous absorption kinetics and site differences Replied, post #11 · Pharmacology › Pharmacokinetics · 26 Jun 2025 · 6 likes I read post #9 twice before replying, because I had assumed the opposite. Accumulation at steady state: with a week-long half-life, steady-state concentration is…
-
A side-effect grading scheme this community uses, and its limits Replied, post #3 · Practice › Side effects · 24 Jun 2025 · 18 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #129 · Devices › Cold chain · 24 Jun 2025 · 33 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #54 · Evidence › Trials · 16 Jun 2025 · 17 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
[2026 update] Gastro-oesophageal reflux: improving or worsening? Replied, post #3 · marked as the solution · Clinical › Comorbidities · 16 Jun 2025 · 22 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
What a documentation review can and cannot tell you Replied, post #4 · Sourcing › Independent verification · 12 Jun 2025 · 3 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #129 · Data & Tools › Calculators · 12 Jun 2025 · 4 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #12 · Sourcing › Regulatory · 2 Jun 2025 · 12 likes I read post #10 twice before replying, because I had assumed the opposite. Regulatory positions change: a compound's status today might differ from its status a year…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #16 · Clinical › Special populations · 30 May 2025 · 29 likes This follows post #13 rather than contradicting it. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #50 · Sourcing › Independent verification · 30 May 2025 · 0 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #124 · Compounds › Cagrilintide & amylin analogues · 29 May 2025 · 4 likes Coming back to post #122, because the follow-up matters more than the original answer. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #7 · Compounds › Semaglutide · 28 May 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The storage lookup and where its data comes from Replied, post #2 · Data & Tools › Calculators · 28 May 2025 · 7 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Storing a pen in use versus a pen unopened Replied, post #16 · Devices › Pens & autoinjectors · 26 May 2025 · 3 likes Worth separating two things that post #12 runs together. Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #42 · Practice › Storage & stability · 16 May 2025 · 30 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Coverage for the indication versus for the drug Replied, post #58 · Access › Insurance & coverage · 8 May 2025 · 27 likes Worth separating two things that post #54 runs together. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but…
-
Deamidation and the close-eluting pair it produces Replied, post #32 · Analytics › Impurities & related substances · 25 Apr 2025 · 2 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Carryover and the ghost peak from last week's standard Replied, post #31 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 28 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
A certificate with no method stated: what can you conclude? Replied, post #30 · Analytics › COA interpretation · 5 Apr 2025 · 27 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Counter-ion content and its effect on measured mass Replied, post #10 · Analytics › Mass spectrometry · 2 Apr 2025 · 27 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #33 · Outcomes › Progress reports · 30 Mar 2025 · 8 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #10 · Evidence › Journal club · 15 Mar 2025 · 29 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Charge states for a 4 kDa peptide, worked through Replied, post #9 · Analytics › Mass spectrometry · 2 Mar 2025 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #53 · Sourcing › Red flags · 16 Feb 2025 · 12 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
UK access routes, dated and sourced — a second dataset Replied, post #38 · Regional › UK & Ireland · 13 Feb 2025 · 8 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #35 · Evidence › Meta-analyses · 1 Feb 2025 · 0 likes I read post #33 twice before replying, because I had assumed the opposite. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria.…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #51 · Analytics › COA interpretation · 24 Jan 2025 · 15 likes Picking up post #48: that is the part I would want checked first. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #46 · Compounds › Oral incretins · 13 Jan 2025 · 16 likes This follows post #43 rather than contradicting it. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #17 · Pharmacology › Receptor biology · 3 Jan 2025 · 6 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Oxidation pathways for methionine and tryptophan Replied, post #12 · Analytics › Impurities & related substances · 26 Dec 2024 · 0 likes Picking up post #9: that is the part I would want checked first. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #95 · Compounds › Semaglutide · 24 Dec 2024 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #50 · Compounds › Semaglutide · 21 Dec 2024 · 26 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #50 · Evidence › Trials · 21 Dec 2024 · 1 like Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Washout with a one-week half-life: the arithmetic Replied, post #75 · Research Methods › N-of-1 designs · 6 Dec 2024 · 4 likes post #74 is right about the mechanism and I think understates the practical bit. Confounding in personal experiments: other things change when you start a medication…
-
Washout with a one-week half-life: the arithmetic Replied, post #22 · Research Methods › N-of-1 designs · 26 Nov 2024 · 0 likes Picking up post #19: that is the part I would want checked first. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #53 · Compounds › Tirzepatide · 25 Nov 2024 · 28 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #132 · Compounds › Repair & healing peptides · 24 Nov 2024 · 0 likes I read post #130 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #44 · Compounds › Tirzepatide · 19 Nov 2024 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Requesting a page: what makes a good request — what changed since Replied, post #48 · Documentation › Wiki requests · 10 Oct 2024 · 15 likes Coming back to post #46, because the follow-up matters more than the original answer. Translation suggestions: if a maintained page should exist in another language,…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #19 · Wellbeing › Mental health · 6 Oct 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why I ask for the gradient before I discuss the number Replied, post #20 · Analytics › HPLC & UHPLC · 14 Sep 2024 · 14 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #44 · Compounds › Semaglutide · 9 Sep 2024 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #81 · Compounds › Retatrutide · 21 Jul 2024 · 7 likes On post #77 — agreed on the reasoning, with one qualification. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
-
Journal club: FLOW and the renal composite, component by component Replied, post #79 · Evidence › Journal club · 16 Jul 2024 · 12 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
The mass-error checker and its intended scope Replied, post #119 · Data & Tools › Calculators · 13 Jul 2024 · 1 like Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #105 · Practice › Dosing & titration · 9 Jul 2024 · 5 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #14 · Practice › Dosing & titration · 6 Jul 2024 · 7 likes post #13 answers the question as asked. The question underneath it is different. How the published trials escalated: they used specific step sizes and intervals. The…
-
The mass-error checker and its intended scope Replied, post #98 · Data & Tools › Calculators · 5 Jul 2024 · 0 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
How this community labels and discusses unrefereed work Replied, post #39 · Evidence › Preprints · 25 Jun 2024 · 3 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…